You just read:

AbbVie Receives Approval from Health Canada for The Combination of VENCLEXTA® with Rituximab as a Treatment for Patients with Chronic Lymphocytic Leukemia

News provided by

AbbVie Canada

Sep 25, 2018, 16:46 ET